The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACCELERON PHARMA INC COM 00434H108 60,759 1,553,937 SH   SOLE   1,553,937 0 0
AKEBIA THERAPEUTICS INC COM 00972D105 29,543 3,100,000 SH   SOLE   3,100,000 0 0
CORVUS PHARMACEUTICALS INC COM 221015100 50,969 4,420,516 SH   SOLE   4,420,516 0 0
CRISPR THERAPEUTICS AG NAMEN AKT H17182108 10,208 223,317 SH   SOLE   223,317 0 0
DERMIRA INC COM 24983L104 15,930 1,993,746 SH   SOLE   1,993,746 0 0
GLAUKOS CORP COM 377322102 17,424 565,165 SH   SOLE   565,165 0 0
INOGEN INC COM 45780L104 435,998 3,549,320 SH   SOLE   3,549,320 0 0
INVUITY INC COM NEW 46187J205 5,251 1,363,848 SH   SOLE   1,363,848 0 0
MENLO THERAPEUTICS INC COM 586858102 51,158 1,361,313 SH   SOLE   1,361,313 0 0
MERUS N V COM N5749R100 26,135 1,410,417 SH   SOLE   1,410,417 0 0
NABRIVA THERAPEUTICS PLC SHS G63637105 14,712 2,924,822 SH   SOLE   2,924,822 0 0
ORTHOPEDIATRICS INC COM 68752L100 9,406 624,591 SH   SOLE   624,591 0 0
RA PHARMACEUTICALS INC COM 74933V108 7,784 1,465,838 SH   SOLE   1,465,838 0 0
SEASPINE HLDGS CORP COM 81255T108 9,333 920,380 SH   SOLE   920,380 0 0
UNUM THERAPEUTICS INC COM 903214104 31,669 665,181 SH   SOLE   665,181 0 0
VERONA PHARMA PLC SPONSORED ADS 925050106 14,815 740,740 SH   SOLE   740,740 0 0
WRIGHT MED GROUP N V RIGHT 03/01/2019 N96617126 6,332 4,622,032 PRN   SOLE   0 0 4,622,032